Medical Device | April 05, 2022
Agilent joins AMBIC to advance biomanufacturing
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The expansion makes Exothera one of the largest viral vector facilities in Europe
Building the future of food in the birthplace of cell-cultured milk
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
The company has started manufacturing the Sputnik Light vaccine
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
The state-of-the-art facility provides a pathway from development to large-scale biologics production
Subscribe To Our Newsletter & Stay Updated
